Can He Wait Out the Dizziness and Stop All Medications?
No, he should not simply wait out the dizziness—this patient requires a much slower, gradual taper of bromazepam given the rapid reduction from ~6 mg to 0.25 mg, as abrupt benzodiazepine discontinuation carries serious risks including seizures and potentially death. 1, 2
The Critical Issue: Benzodiazepine Withdrawal Risk
The primary concern here is not the citalopram discontinuation syndrome (which is causing the dizziness), but rather the dangerously rapid bromazepam taper.
Why This Matters:
- Benzodiazepine withdrawal is medically dangerous: Abrupt withdrawal can cause rebound anxiety, hallucinations, seizures, delirium tremens, and in rare cases, death 1, 2
- Greater risks than opioid withdrawal: Guidelines explicitly state that benzodiazepine withdrawal carries greater risks than opioid withdrawal 1
- The taper was too fast: Reducing from ~6 mg to 0.25 mg represents a massive reduction that should have occurred over many weeks to months, not rapidly
Recommended Management Strategy
1. Stabilize the Benzodiazepine First
- Do not discontinue the remaining 0.25 mg bromazepam yet
- Consider temporarily increasing back to a slightly higher dose if severe withdrawal symptoms emerge
- A commonly used safe tapering schedule is 25% dose reduction every 1-2 weeks 1, 2
- From 6 mg, this should have taken 3-6 months minimum
2. Address the Citalopram Discontinuation Syndrome
The dizziness is likely from SSRI discontinuation syndrome, which is well-documented with citalopram 3, 4:
Characteristic symptoms include:
- Dizziness, vertigo, imbalance
- Sensory disturbances (paresthesias, "electric shock" sensations)
- Fatigue, lethargy, headache
- Nausea, anxiety, irritability
Management options:
- If tolerable: These symptoms are generally self-limiting and resolve within 1-2 weeks 5
- If intolerable: Reinstate citalopram at the previous dose (symptoms typically resolve within 24 hours), then taper more gradually 4, 6
- Gradual dose reduction is recommended: decrease by smaller increments over weeks rather than abrupt cessation 4
3. Proper Discontinuation Sequence
The correct order matters:
- When patients are on both benzodiazepines and other medications requiring taper, guidelines recommend tapering other medications first when possible 1
- However, in this case, the citalopram is already stopped—focus now on the benzodiazepine
Specific Action Plan
Immediate (Week 1-2):
- Maintain current bromazepam 0.25 mg
- Monitor for withdrawal symptoms (anxiety, tremor, seizures, confusion)
- Allow citalopram discontinuation symptoms to resolve (typically 1-2 weeks)
If dizziness is intolerable:
- Consider restarting citalopram 15 mg briefly, then taper over 4-6 weeks using smaller decrements
- Example: 15 mg → 10 mg (2 weeks) → 5 mg (2 weeks) → 2.5 mg (2 weeks) → stop 7
Bromazepam taper (Weeks 2-12+):
- From 0.25 mg, reduce by approximately 25% every 1-2 weeks
- Example: 0.25 mg → 0.19 mg → 0.125 mg → 0.06 mg → stop
- This may require compounding or liquid formulations for very small doses
- Cognitive behavioral therapy increases tapering success rates 1, 2
Critical Warnings
Do NOT:
- Abruptly stop the remaining bromazepam—this is medically dangerous
- Assume all symptoms are just "discontinuation syndrome" that will pass—benzodiazepine withdrawal can be life-threatening
- Rush the process—proper benzodiazepine discontinuation takes months
Monitor for:
- Seizures (medical emergency)
- Severe anxiety, agitation, confusion
- Hallucinations or delirium
- Rebound insomnia
The Bottom Line
While the dizziness from citalopram discontinuation is uncomfortable but generally safe to tolerate, the rapid bromazepam taper is the real danger. This patient needs close medical supervision, a much slower benzodiazepine taper over several months, and potentially reinstatement of citalopram if discontinuation symptoms are intolerable. Simply "waiting it out" risks serious medical complications from benzodiazepine withdrawal.